Latest California Healthline Stories
One Northern California physician is a foot soldier in the fight against a surge of hepatitis C, mainly among young drug users who share infected needles.
An explosive report prepared by a SynerMed executive alleges the California firm, which oversaw care for 1.2 million patients, fabricated documents and violated state and federal regulations for years. The state says it left low-income patients on Medicaid managed care in “imminent danger.”
Regulators are scrutinizing claims by companies that their alternative, slimmed-down health plans satisfy Obamacare coverage requirements. California Insurance Commissioner Dave Jones said his agency will investigate whether one of those companies is selling such plans in California in violation of state law.
The state insurance exchange is committing nearly five times more money than the federal government on ads urging people to sign up for health insurance, reflecting conflicting attitudes toward the Affordable Care Act.
State leaders vow to protect consumers from a presidential order to resurrect a health plan model that they say could destabilize the insurance market.
The Department of Managed Health Care cited one example in which consumers and advocates had to call the insurer 22 times to contest a decision. Still, the complaint still was not resolved until the department became involved.
State regulators and insurers are looking into SynerMed, which medical groups depend upon to handle their finances and business operations. The groups, serving 1 million patients, fear a messy fallout.
The state’s Department of Public Health said that suspected cases of the fungal infection increased by more than one-third in the first 10 months, compared with the same period in 2016, putting it on pace to break last year’s record high.
Amid financial losses and the uncertainty of federal funding under Obamacare, health insurers find there’s money to be made in Medicaid.
The legalization of recreational marijuana in California and other states poses an added challenge for drug education programs targeting youths.